theravia
Company Details
Status: Private
Employees: 101-250
Location:
16 rue Montrosier, Neuilly - sur - Seine, Ile de France 92200, FR
Type:
sample
Technology:
sample
sample
About: Theravia is an international pharmaceutical laboratory based in France, focusing on rare, neglected, and debilitating diseases. Formed from the merger of Addmedica and CTRS, the company operates in over 35 countries across five continents. Theravia is dedicated to addressing unmet medical needs through innovative therapies and strategic partnerships.
The company develops, registers, and promotes specialized medical products, including pharmaceuticals, medical devices, and diagnostics. Their portfolio features six registered products, such as Siklos for sickle cell disease and Orphacol for genetic disorders affecting bile acid production. Theravia collaborates with research groups and healthcare institutions to enhance disease awareness and improve treatment accessibility for over 15,000 patients globally.
With more than 20 years of experience in rare disease therapeutics, Theravia emphasizes patient-centric solutions and adaptive strategies. The company has established over 30 partnerships worldwide, reflecting its commitment to advancing healthcare for those with rare metabolic, hematologic, and immunologic conditions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
theravia | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.